$BMRN BIOMARIN PHARMACEUTICAL INC Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in BIOMARIN PHARMACEUTICAL INC. Find out how many shares they currently own, their value and whether they buy or sell their shares.
BIOMARIN PHARMACEUTICAL INC Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| Acosta Andrea | GVP, Chief Accounting Officer | 19,068 | 1,695,336 | Mar 17 2021 | |||
| Ajer Jeffrey Robert | EVP, Chief Commercial Officer | 58,250 | 5,179,008 | Apr 09 2021 | |||
| Ajer Jeffrey Robert | SVP, Chief Commercial Of | 25,380 | 2,256,536 | Feb 19 2014 | |||
| ANDERSON ELIZABETH M | Director | 8,790 | 781,519 | May 29 2020 | |||
| ASELAGE STEVE | SVP, Global Commercial Dev | 32,034 | 2,848,143 | Apr 03 2008 | |||
| ASELAGE STEVE | SVP, Chief Business Officer | 48,416 | 4,304,667 | Jun 09 2009 | |||
| BAFFI ROBERT | President, Global Mfg/Tech Ops | 117,138 | 10,414,740 | Mar 24 2020 | |||
| BAFFI ROBERT | SVP, Technical Operations | 18,493 | 1,644,213 | Dec 06 2004 | |||
| BAFFI ROBERT | EVP, Technical Operations | 99,200 | 8,819,872 | Oct 31 2014 | |||
| BAFFI ROBERT | EVP, Technical Operations | 99,200 | 8,819,872 | Jun 06 2014 | |||
| BATE KENNETH | Director | 11,875 | 1,055,806 | Jun 18 2015 | |||
| BATE KENNETH | Director | 10,775 | 958,005 | Jun 06 2014 | |||
| BIENAIME JEAN JACQUES | Chief Executive Officer | 304,839 | 27,103,235 | Jun 23 2021 | |||
| BIENAIME JEAN JACQUES | Chief Executive Officer | 6,695 | 595,252 | Oct 02 2007 | |||
| BIENAIME JEAN JACQUES | Chief Executive Officer | 3,567 | 317,142 | May 13 2008 | |||
| BIENAIME JEAN JACQUES | Chief Executive Officer | 48,740 | 4,333,473 | Mar 01 2010 | |||
| BIENAIME JEAN JACQUES | Chief Executive Officer | 225,157 | 20,018,709 | Jan 13 2015 | |||
| BIENAIME JEAN JACQUES | Chief Executive Officer | 54,740 | 4,866,933 | Feb 07 2014 | |||
| BIENAIME JEAN JACQUES | Chief Executive Officer | 47,940 | 4,262,345 | Jan 27 2010 | |||
| BIOMARIN PHARMACEUTICAL INC | 10% Owner | 6,666,667 | 592,733,363 | Dec 12 2012 | |||
| Cooper Jeffrey H | Chief Financial Officer | 0 | 0 | Aug 23 2004 | |||
| Cooper Jeffrey H | SVP, Chief Financial Officer | 40,104 | 3,565,647 | Feb 28 2012 | |||
| Cooper Jeffrey H | SVP, Chief Financial Officer | 16,502 | 1,467,193 | Jun 09 2009 | |||
| Cooper Jeffrey H | SVP, Chief Financial Officer | 41,089 | 3,653,223 | May 16 2012 | |||
| CRISTIANI FRANZ L | Director | 0 | 0 | Jun 15 2004 | |||
| CRISTIANI FRANZ L | Director | 0 | 0 | Jun 15 2006 | |||
| Davis George Eric | EVP, General Counsel | 68,781 | 6,115,319 | May 04 2021 | |||
| Davis George Eric | VP, General Counsel | 0 | 0 | Dec 19 2008 | |||
| Davis George Eric | VP, General Counsel | 20,453 | 1,818,476 | Dec 04 2009 | |||
| Davis George Eric | SVP, General Counsel | 60,656 | 5,392,925 | Feb 19 2014 | |||
| Dere Willard H | Director | 13,290 | 1,181,614 | Jun 30 2020 | |||
| DRAPEAU LOUIS | Chief Executive Officer | 7,243 | 643,975 | Aug 20 2004 | |||
| DRAPEAU LOUIS | Chief Executive Officer | 14,934 | 1,327,782 | May 09 2005 | |||
| FALBERG KATHRYN E | Director | 3,300 | 293,403 | Jul 19 2016 | |||
| FUCHS HENRY J | President, Worldwide R&D | 106,142 | 9,437,085 | Mar 23 2021 | |||
| FUCHS HENRY J | EVP, Chief Medical Officer | 76,550 | 6,806,061 | Nov 12 2014 | |||
| FUCHS HENRY J | EVP, Chief Medical Officer | 76,550 | 6,806,061 | Jun 06 2014 | |||
| GREY MICHAEL G | Director | 45,340 | 4,031,179 | Aug 05 2020 | |||
| GREY MICHAEL G | Director | 8,750 | 777,963 | May 14 2009 | |||
| GREY MICHAEL G | Director | 25,150 | 2,236,087 | Jun 06 2014 | |||
| GREY MICHAEL G | Director | 0 | 0 | May 27 2008 | |||
| Guyer Charles Greg | EVP, Chief Technical Officer | 45,681 | 4,061,498 | May 05 2021 | |||
| HERON ELAINE J | Director | 72,088 | 6,409,344 | May 27 2021 | |||
| HERON ELAINE J | Director | 19,525 | 1,735,968 | Jun 06 2014 | |||
| HERON ELAINE J | Director | 32,500 | 2,889,575 | Jul 08 2008 | |||
| HERON ELAINE J | Director | 37,500 | 3,334,125 | May 27 2009 | |||
| Ho Maykin | Director | 2,350 | 208,939 | Feb 19 2021 | |||
| HOMBACH ROBERT J. | Director | 21,330 | 1,896,450 | May 27 2021 | |||
| KAKKIS EMIL D | SVP, Business Operations | 26,110 | 2,321,440 | May 07 2004 | |||
| KAKKIS EMIL D | Chief Medical Officer | 39,621 | 3,522,703 | Mar 04 2009 | |||
| KAKKIS EMIL D | SVP, Chief Medical Officer | 29,574 | 2,629,424 | Jan 10 2006 | |||
| KAKKIS EMIL D | Chief Medical Officer | 127,304 | 11,318,599 | Aug 05 2008 | |||
| KLEIN JOSEPH III | Director | 37,500 | 3,334,125 | Mar 04 2009 | |||
| KLEIN JOSEPH III | Director | 35,000 | 3,111,850 | Mar 10 2010 | |||
| LANDAU JEFFREY | SVP, Administration | 2,028 | 180,309 | May 07 2004 | |||
| LANDAU JEFFREY | SVP, Administration | 2,740 | 243,613 | Dec 06 2004 | |||
| LAPALME PIERRE | Director | 31,250 | 2,778,438 | Jun 18 2015 | |||
| LAPALME PIERRE | Director | 30,150 | 2,680,637 | Jun 06 2014 | |||
| LAPALME PIERRE | Director | 1,500 | 133,365 | Dec 04 2008 | |||
| LAPALME PIERRE | Director | 13,750 | 1,222,513 | May 14 2009 | |||
| LAWLIS V BRYAN | Director | 23,970 | 2,131,173 | May 27 2021 | |||
| LAWLIS V BRYAN | Director | 11,800 | 1,049,138 | Jun 06 2014 | |||
| LEWIS ALAN | Director | 25,590 | 2,275,207 | Jun 06 2019 | |||
| LEWIS ALAN | Director | 21,400 | 1,902,674 | Dec 08 2014 | |||
| MEIER RICHARD A | Director | 99,340 | 8,832,319 | May 07 2021 | |||
| MEIER RICHARD A | Director | 24,150 | 2,147,177 | Jun 06 2014 | |||
| MEIER RICHARD A | Director | 3,250 | 288,958 | Mar 04 2009 | |||
| Mueller Brian | EVP, Chief Financial Officer | 31,357 | 2,787,951 | May 11 2021 | |||
| Mueller Brian | VP, Corporate Controller | 4,593 | 408,364 | Dec 03 2014 | |||
| PRICE FREDRIC D | Chief Executive Officer | 79,285 | 7,049,229 | May 07 2004 | |||
| PYOTT DAVID E I | Director | 29,840 | 2,653,074 | Sep 01 2020 | |||
| SAGER ERICH | Director | 3,309 | 294,203 | Feb 27 2006 | |||
| SAGER ERICH | Director | 3,309 | 294,203 | Dec 06 2005 | |||
| Slamon Dennis | Director | 22,915 | 2,037,373 | May 29 2020 | |||
| SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | 47,686 | 4,239,762 | Jun 07 2019 | |||
| SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | 68,733 | 6,111,051 | Feb 10 2015 | |||
| SPIEGELMAN DANIEL K | EVP, Chief Financial Officer | 64,273 | 5,714,512 | Feb 19 2014 | |||
| STARR CHRISTOPHER M | SVP, Chief Scientific Officer | 305,176 | 27,133,198 | Jun 04 2004 | |||
| STARR CHRISTOPHER M | SVP, Chief Scientific Officer | 0 | 0 | Jan 10 2005 | |||
| STARR CHRISTOPHER M | SVP, Chief Scientific Officer | 295,176 | 26,244,098 | Dec 02 2005 | |||
| Swiedler Stuart J | SVP, Clinical Affairs | 12,000 | 1,066,920 | Jul 08 2008 | |||
| Swiedler Stuart J | SVP, Clinical Affairs | 10,000 | 889,100 | Nov 23 2005 | |||
| URQUHART JOHN | Director | 0 | 0 | Jul 28 2003 | |||
| URQUHART JOHN | Director | 0 | 0 | Jul 29 2004 | |||
| WILLIAMS GWYNN | Director | 812,565 | 72,245,154 | Jul 29 2003 | |||
| WILLIAMS GWYNN | Director | 0 | 0 | Dec 02 2004 | |||
| Wood Mark | VP, Human Resources | 650 | 57,792 | Jan 21 2009 | |||
| Wood Mark | VP, Human Resources | 20,277 | 1,802,828 | May 23 2013 | |||
| Wood Mark | VP, Human Resources | 650 | 57,792 | Jul 10 2008 | |||
| Wood Mark | VP, Human Resources | 31,114 | 2,766,346 | May 10 2012 | |||
| Wood Mark | VP, Human Resources | 8,081 | 718,482 | Apr 14 2010 | |||
| YOUNG WILLIAM D | Director | 11,875 | 1,055,806 | Jun 18 2015 | |||
| YOUNG WILLIAM D | Director | 10,775 | 958,005 | Jun 06 2014 |